That isn't what it says they're claiming at all. "this imposes a practical and financial strain on the scalability" is just a way of saying that it gets more expensive for bigger people.

They did the study in part to determine if it's actually necessary to scale up for people whose additional size is mostly fat, or if they can take the same (smaller, cheaper) dose as someone who is their height but has less body fat.